- +86-898-31320087
- info@medical-ivd.com
Search
Cardiac Markers List
Cardiac markers are substances that are released into the blood when the heart is damaged or stressed. Tests of these markers are used to help diagnose acute coronary syndrome (ACS) and cardiac ischemia, conditions associated with insufficient blood flow to the heart.
The main markers of myocardial injury were troponin T, troponin I, creatine kinase isoenzyme mass (CK MB) and myoglobin. Troponin is composed of three subunits.
| Product Name | Catalog # | Source | Format | Purification | Concentration | Lot |
| Recombinant CK-MM Protein PDF Download | L4C00703 | E. Coli | Purified Liquid MW: 43KD | Purified>85% | 3mg/ml | L20200301 |
| Purified D-dimmer Antigen PDF Download | L4C00801 | Human serum | Affinity purified | 5mg/ml | L20200501 | |
| Recombinant Troponin C PDF Download | L4C01301 | E. Coli | 20mM TrisHCl buffer (pH 8.0) , 5% Trehalose, 1mMEDTA | >85% by SDS-PAGE | 1.1mg/ml | L20200901 |
| Purified cTnI Protein | ||||||
| Recombinant cTnI Protein PDF Download | L4C00102 | Expressed in E. coli | Purified | Purified, >90% pure by SDS-PAGE | 1.1 mg/ml (Roche ECLIA) | L20200901 |
| Recombinant MYO Antigen PDF Download | L4C00402 | Expressed in E. coli | Purified, >85% pure by SDS-PAGE | 1.5mg/ml (activity Concentration) | L20201201 | |
| Recombinant NT-PRO-BNP Protein PDF Download | L4C00302 | E. coli | Purified, Liquid | >85% pure (SDS-PAGE) | 1 mg/ml (Roche ECLIA) | L20200101 |
| Human Recombinant ST2 Protein PDF Download | L4C01501 | E.coli | Affinity purified | 1.1mg/ml | L20201101 |
Myocardial injury markers are increasingly becoming the markers of screening, monitoring, follow-up and prognosis of myocardial injury such as MI and AMI. Myocardial projects, mature antigens, and gradually perfect antibodies.
Myoglobin is the best early marker for myocardial injury.CTnI / cTnT was unanimously rated by the American and European Heart Association as a highly specific and sensitive diagnostic marker for acute myocardial infarction.The sensitivity and specificity of CK mbmass detection are much higher than CK-MB activity. Therefore, when cTnI or cTnT detection is not carried out, CK mbmass can be used to assist clinical diagnosis. It is close to troponin in the diagnosis of acute coronary syndrome and the evaluation of the degree of myocardial injury, as well as in sensitivity and specificity.
